Albert Adam

4.6k total citations
100 papers, 3.7k citations indexed

About

Albert Adam is a scholar working on Genetics, Oncology and Immunology. According to data from OpenAlex, Albert Adam has authored 100 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Genetics, 27 papers in Oncology and 27 papers in Immunology. Recurrent topics in Albert Adam's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (75 papers), Peptidase Inhibition and Analysis (27 papers) and Mast cells and histamine (21 papers). Albert Adam is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (75 papers), Peptidase Inhibition and Analysis (27 papers) and Mast cells and histamine (21 papers). Albert Adam collaborates with scholars based in Canada, United States and Belgium. Albert Adam's co-authors include Giuseppe A. Molinaro, François Marceau, Nancy J. Brown, Charles Blais, Yves Lepage, J. Damas, Marie Eve Moreau, Nicole Gervais, Jean‐Christophe Leroux and Nancy Garbacki and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Albert Adam

99 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Albert Adam Canada 33 2.1k 921 692 684 652 100 3.7k
Noboru Fukuda Japan 36 698 0.3× 825 0.9× 169 0.2× 2.1k 3.0× 400 0.6× 234 4.4k
Shinji Takai Japan 34 650 0.3× 1.0k 1.1× 175 0.3× 1.5k 2.2× 1.1k 1.7× 147 3.8k
Denan Jin Japan 36 730 0.3× 1.3k 1.4× 134 0.2× 1.5k 2.1× 1.5k 2.3× 156 4.3k
Yasufumi Katanasaka Japan 29 448 0.2× 460 0.5× 585 0.8× 1.4k 2.1× 381 0.6× 89 3.2k
Paul Kessler United States 26 1.5k 0.7× 1.3k 1.4× 74 0.1× 1.9k 2.8× 168 0.3× 46 5.2k
Mitsuhiko Okigaki Japan 34 270 0.1× 441 0.5× 318 0.5× 1.7k 2.5× 834 1.3× 65 4.2k
Bruce A. Hug United States 23 334 0.2× 502 0.5× 601 0.9× 1.6k 2.3× 590 0.9× 47 3.6k
Pablo Garcı́a de Frutos Spain 36 413 0.2× 346 0.4× 1.3k 1.8× 790 1.2× 1.7k 2.7× 92 3.9k
Qingzhong Xiao United Kingdom 44 348 0.2× 549 0.6× 239 0.3× 3.3k 4.9× 1.1k 1.7× 128 5.9k
Daiana Weiss United States 32 233 0.1× 940 1.0× 141 0.2× 1.5k 2.2× 1.1k 1.6× 60 4.5k

Countries citing papers authored by Albert Adam

Since Specialization
Citations

This map shows the geographic impact of Albert Adam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Adam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Adam more than expected).

Fields of papers citing papers by Albert Adam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Adam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Adam. The network helps show where Albert Adam may publish in the future.

Co-authorship network of co-authors of Albert Adam

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Adam. A scholar is included among the top collaborators of Albert Adam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Adam. Albert Adam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gera, Lajos, Caroline Roy, Marie‐Thérèse Bawolak, et al.. (2011). Met-Lys-bradykinin-Ser-Ser, a peptide produced by the neutrophil from kininogen, is metabolically activated by angiotensin converting enzyme in vascular tissue. Pharmacological Research. 64(5). 528–534. 13 indexed citations
2.
Adam, Albert, et al.. (2010). Effect of interferon-γ on inflammatory cytokine-induced bradykinin B1 receptor expression in human vascular cells. European Journal of Pharmacology. 647(1-3). 117–125. 25 indexed citations
3.
Adam, Albert, et al.. (2010). Persönlichkeitsentwicklungsstörungen bei Kindern und Jugendlichen. 2 indexed citations
5.
Drouet, Christian, Anik Désormeaux, D. Ponard, et al.. (2008). Metallopeptidase activities in hereditary angioedema: Effect of androgen prophylaxis on plasma aminopeptidase P. Journal of Allergy and Clinical Immunology. 121(2). 429–433. 88 indexed citations
6.
Bawolak, Marie‐Thérèse, Lajos Gera, Johanne Bouthillier, et al.. (2008). A fluorescent version of the bradykinin B2 receptor antagonist B-9430: Pharmacological characterization and use in live cell imaging. Peptides. 29(9). 1626–1630. 12 indexed citations
7.
Adam, Albert, et al.. (2007). Physiopathologie des effets secondaires aigus des inhibiteurs de l’enzyme de conversion de l’angiotensine.. Bulletin de l Académie Nationale de Médecine. 191(7). 1433–1444. 7 indexed citations
8.
Byrd, James Brian, Albert Adam, & Nancy J. Brown. (2006). Angiotensin-Converting Enzyme Inhibitor-Associated Angioedema. Immunology and Allergy Clinics of North America. 26(4). 725–737. 125 indexed citations
9.
Gera, Lajos, Jean‐Philippe Fortin, Albert Adam, John M. Stewart, & François Marceau. (2006). Discovery of a Dual-Function Peptide That Combines Aminopeptidase N Inhibition and Kinin B1 Receptor Antagonism. Journal of Pharmacology and Experimental Therapeutics. 317(1). 300–308. 15 indexed citations
11.
Moreau, Marie Eve, Patrice Dubreuil, Giuseppe A. Molinaro, et al.. (2005). Expression of Metallopeptidases and Kinin Receptors in Swine Oropharyngeal Tissues: Effects of Angiotensin I-Converting Enzyme Inhibition and Inflammation. Journal of Pharmacology and Experimental Therapeutics. 315(3). 1065–1074. 23 indexed citations
12.
Fortin, Jean‐Philippe, Georges E. Rivard, Albert Adam, & François Marceau. (2005). Studies on rabbit natural and recombinant tissue factors: intracellular retention and regulation of surface expression in cultured cells. American Journal of Physiology-Heart and Circulatory Physiology. 288(5). H2192–H2202. 11 indexed citations
13.
Lapointe, Nathalie, James N. Tsoporis, Thomas G. Parker, et al.. (2003). Comparative effects of a vasopeptidase inhibitor vs. an angiotensin convertin enzyme inhibitor on cardiomyocyte apoptosis in rats with heart failure. Molecular and Cellular Biochemistry. 254(1-2). 235–245. 5 indexed citations
14.
Lapointe, Nathalie, Charles Blais, Albert Adam, et al.. (2002). Comparison of the effects of an angiotensin-converting enzyme inhibitor and a vasopeptidase inhibitor after myocardial infarction in the rat. Journal of the American College of Cardiology. 39(10). 1692–1698. 39 indexed citations
15.
Isordia‐Salas, Irma, Robin A. Pixley, Fengling Li, et al.. (2002). Chronic intestinal inflammation and angiogenesis in genetically susceptible rats is modulated by kininogen deficiency. International Immunopharmacology. 2(13-14). 1895–1905. 8 indexed citations
17.
Colman, Robert W., R. Balfour Sartor, Albert Adam, Raul A. DeLa Cadena, & Antoni Stadnicki. (1998). The plasma kallikrein-kinin system in sepsis, inflammatory arthritis, and enterocolitis. Clinical Reviews in Allergy & Immunology. 16(4). 365–384. 24 indexed citations
18.
Lenaerts, Vincent, et al.. (1995). Radioimmunoassay for hexarelin, a peptidic growth hormone secretagogue, and its pharmacokinetic studies. Peptides. 16(7). 1301–1306. 4 indexed citations
19.
Tijssen, Peter & Albert Adam. (1991). Enzyme-linked immunosorbent assays and developments in techniques using latex beads. Current Opinion in Immunology. 3(2). 233–237. 10 indexed citations
20.
Damas, J., et al.. (1990). Proteinase inhibitors, kinins and the inflammatory reaction induced by sponge implantation in rats. European Journal of Pharmacology. 175(3). 341–346. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026